Ipamorelin 20mg — Vial Spec, Reconstitution Math & COA

Overview of Ipamorelin 20mg Vial Specifications

A 20mg vial of ipamorelin contains 20 milligrams of highly purified, lyophilized synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) sealed under inert nitrogen atmosphere. This larger mass format is engineered for research facilities conducting high-frequency bioassays, automated robotic pipetting protocols, or longitudinal preclinical animal models that require consistent, single-lot dosing over extended timelines. Purchasing or working with a single 20mg lyophilized cake minimizes lot-to-lot variance across multi-week studies.

It should be noted that standard PX1 inventory cataloging prioritizes primary assay sizes, such as individual 2mg and 5mg vials found on our main Ipamorelin product page. However, custom high-volume fills—including 20mg single-vial unit specifications—are frequently produced for institutional procurement, bulk research accounts, and specialized laboratory requests accessed through our wholesale portal. Regardless of the specific vial fill size selected across our entire catalog of all research peptides, the underlying chemical identity, sequence integrity, and strict purity specifications remain identical.

Molecular Profile and Ghrelin Receptor Selectivity

Ipamorelin is classified as a synthetic pentapeptide growth hormone secretagogue (GHS) that acts as a selective agonist at the growth hormone secretagogue receptor 1a (GHS-R1a). Preclinical literature identifies ipamorelin as one of the most selective secretagogues in its chemical class. Unlike early-generation ghrelin mimetics, ipamorelin stimulates growth hormone (GH) secretion from anterior pituitary cells without causing significant collateral release of adrenocorticotropic hormone (ACTH), cortisol, or prolactin.

In vitro pituitary cell assays and in vivo rodent models demonstrate that ipamorelin induces a pulsatile pattern of GH secretion that closely mimics endogenously generated growth hormone spikes. Because its binding affinity is specific to GHS-R1a, preclinical studies suggest that target tissue responses can be evaluated without the confounding systemic metabolic effects driven by glucocorticoid spike artifact. This receptor specificity makes the compound a valuable tool for research focusing on somatotroph signaling, cellular growth pathways, and tissue preservation.

Reconstitution Calculations for a 20mg Fill Mass

Reconstituting a high-mass lyophilized cake such as an ipamorelin 20mg vial requires precise volumetric planning to achieve desired working concentrations while managing total liquid volume within standard laboratory vials. Because 20mg represents a substantial mass of peptide powder, ensuring complete dissolution in sterile bacteriostatic water or standard laboratory diluent is critical prior to downstream dilution.

The fundamental concentration formula is Concentration (C) = Mass (m) / Volume (V). Below are standard reconstitution volumetric reference points for a 20mg solid mass:

• Reconstitution with 1.0 mL diluent yields a final concentration of 20.0 mg/mL (20.0 µg/µL). This hyper-concentrated stock is suitable for minimal-volume storage or automated microplate dispensing systems.

• Reconstitution with 2.0 mL diluent yields a final concentration of 10.0 mg/mL (10.0 µg/µL). This provides a straightforward 1:10 scaling metric for serial laboratory dilutions.

• Reconstitution with 3.0 mL diluent yields a final concentration of 6.67 mg/mL (6.67 µg/µL).

• Reconstitution with 5.0 mL diluent yields a final concentration of 4.0 mg/mL (4.0 µg/µL), facilitating accurate manual pipetting for larger volumetric working assays.

For complex, multi-diluent protocols or non-standard fill masses, researchers should utilize our interactive reconstitution calculator to verify custom concentrations, target dose volumes, and solvent ratios.

Aliquot Strategy and Laboratory Handling

Once a 20mg vial is reconstituted into liquid stock, subject matter experts advise against repeated freeze-thaw cycles. Subjecting peptide solutions to alternating freezing and thawing leads to peptide chain aggregation, physical denaturation, and measurable loss of biological activity in cell-based assays.

To maximize shelf life and protocol reproducibility, the primary reconstituted stock should immediately be subdivided into single-use microcentrifuge aliquots using polypropylene sterile tubes. Working aliquots should be designated based on daily or weekly assay requirements. Reconstituted solution should be diluted gently by running diluent slowly down the glass wall of the vial, followed by gentle swirling. Vortexing or aggressive mechanical agitation must be strictly avoided, as shear stress disrupts the secondary structure of synthesized peptide chains.

Analytical Quality Control and Lot-Matched COA Verification

Because large-format peptides are frequently utilized in high-throughput or sensitive assay conditions, rigorous analytical verification is non-negotiable. Every production batch of ipamorelin undergoes comprehensive analytical testing within an ISO 17025 accredited testing facility to establish pure, verifiable identity and stability metrics.

Quality assurance verification includes High-Performance Liquid Chromatography (HPLC) to establish purity (>98.0%) and Mass Spectrometry (MS) to verify precise molecular weight matching the theoretical mass of 711.86 Da. Furthermore, bacterial endotoxin testing via Chromogenic Reagent LAL assay ensures endotoxin levels remain below strictly monitored limits (<0.01 EU/mg) suitable for delicate cellular research. Every shipment is linked to a lot-specific report accessible via our central COA verification directory.

Vial Size Selection: 20mg vs. Smaller Standard Formulations

Determining whether a 20mg vial format or smaller individual fill sizes (such as 2mg or 5mg) are optimal depends entirely on the design, duration, and scale of the planned research protocol.

A 20mg vial size is optimal for high-throughput screening, multi-plate automated liquid handlers, or large longitudinal rodent cohorts where utilizing a single batch parameter reduces research variables. Conversely, exploratory studies, single-assay validations, or protocols requiring long storage periods between low-volume uses are better served by smaller 2mg or 5mg vials. Using smaller fill sizes ensures that reconstituted solution is completely exhausted prior to any potential aqueous degradation over time.

Comparative Analysis: Ipamorelin vs. Related Secretagogues

When evaluating growth hormone secretagogues within preclinical models, researchers frequently compare ipamorelin against other classical GHS-R1a ligands and growth hormone releasing hormone (GHRH) analogs to determine optimal experimental controls.

In comparative animal models, first-generation hexapeptides such as GHRP-6 and GHRP-2 demonstrate robust GH release but trigger concomitant increases in systemic cortisol, ACTH, and prolactin, alongside significant appetite stimulation mediated by central ghrelin pathways. Conversely, ipamorelin offers an isolated, highly selective somatotroph response without provoking secondary neuroendocrine elevations. When combined in synergistic preclinical protocols with GHRH peptide mimetics such as CJC-1295, researchers observe amplified, biphasic growth hormone pulses distinct from single-agent baseline controls.

Storage Parameters and Cold-Chain Integrity

Maintaining cold-chain integrity from manufacturing through laboratory bench storage is critical for preserving peptide sequence integrity. Lyophilized ipamorelin 20mg powder remains stable at room temperature for brief transit periods, but long-term storage parameters require desiccated preservation at -20°C or -80°C to prevent hydrolysis or moisture degradation.

Upon reconstitution, liquid working stocks must be stored under refrigeration at 2°C to 8°C and utilized within 14 to 28 days depending on the solvent composition (e.g., sterile bacteriostatic water containing 0.9% benzyl alcohol). Frozen liquid aliquots stored at -20°C remain stable for extended periods, provided they are shielded from light and kept free from temperature fluctuations caused by auto-defrost freezer cycles.

High-Throughput Protocol Design and Research Library Access

Designing rigorous in vitro pituitary culture assays or systemic receptor binding studies requires precise reagent handling, documented solvent compatibility data, and standardized baseline controls. Advanced protocol design considerations, solubility matrices, and comparative published literature can be reviewed directly inside the PX1 online research library.

By maintaining strict adherence to laboratory-grade handling, accurate concentration calculations, and verification of third-party analytical testing, investigators ensure the highest level of experimental reproducibility across all growth hormone secretagogue models.